AI is about to change healthcare. These 37 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Expeditors today, you need to believe that its asset-light logistics model, high returns on equity, and disciplined capital returns can justify a richer valuation than many peers, even with only modest growth expectations. The latest special calls on AI-driven freight demand and the U.S. Customs Enforcement Executive Order reinforce that near term catalysts are still tied to hyperscaler shipping needs, air and ocean rate conditions, and how efficiently Expeditors adapts its technology and compliance systems. These updates look incrementally positive for the story, but probably do not transform it on their own, especially with the share price already well above some fair value estimates and earnings still forecast to grow slowly. The bigger swing factor remains whether pricing power and volumes can support current multiples without a setback in trade or enforcement costs.
However, tighter customs rules could still pressure margins in ways investors should understand. Expeditors International of Washington's share price has been on the slide but might be up to 12% below fair value. Find out if it's a bargain.Explore 2 other fair value estimates on Expeditors International of Washington - why the stock might be worth 11% less than the current price!
Disagree with this assessment? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Our daily scans reveal stocks with breakout potential. Don't miss this chance:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com